Coripharma Holding hf Sustainability Reports

Coripharma Holding hf. operates as a generic pharmaceutical company that develops, manufactures, and out-licenses solid oral dosage generic drugs. Its manufacturing facilities handle contract development and manufacturing organization (CDMO) services for international markets.

Sector: Manufacturing

Country: Iceland

Exchange: Unlisted

LEI: 254900LH1C66RF6HHI04

3 reports from 2023 to 2025

• Coripharma Holding hf 2025 Sustainability Report
• Coripharma Holding hf 2024 Sustainability Report
• Coripharma Holding hf 2023 Sustainability Report